The effect of COVID‐19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross‐sectional, comparative study

Comorbidities and Age Are Associated With Persistent COVID-19 PCR Positivity

(2021) Mohammed Aldhaeefi et al.   Frontiers in Cellular and Infection Microbiology

A novel coronavirus outbreak of global health concern

(2020) Chen Wang et al.   LANCET

Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration

(2020) Giovanni Damiani et al.   Dermatologic Therapy

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

(2020) Hasan K. Siddiqi et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy

(2020) Andrea Carugno et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriasis and COVID ‐19: A narrative review with treatment considerations

(2020) Ömer Faruk Elmas et al.   Dermatologic Therapy

Omalizumab and COVID‐19 treatment: Could it help?

(2020) Ayman Abdelmaksoud et al.   Dermatologic Therapy

What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID ‐19 or asymptomatic infections due to SARS‐CoV ‐2?

(2020) Paulo Ricardo Criado et al.   Dermatologic Therapy

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

(2020) Giacomo Grasselli et al.   JAMA Internal Medicine

The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria

(2020) Emek Kocatürk et al.   ALLERGY

COVID‐19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases

(2020) Erhan Ayhan et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

(2020) Mohitosh Biswas et al.   INTERVIROLOGY

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

(2018) T. Zuberbier et al.   ALLERGY

Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab

(2018) Michelle A. Gill et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab Updosing for Better Disease Control in Chronic Spontaneous Urticaria Patients

(2018) Emek Kocatürk et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Respiratory infections associated with anti-TNFα agents

(2017) E. Blanchard et al.   MEDECINE ET MALADIES INFECTIEUSES

A prospective ten-year follow-up of patients with chronic urticaria

(2016) P.C.L. Dionigi et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children

(2016) David B. Kantor et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis

(2015) J.M. Pinto   RHINOLOGY

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

(2013) Marcus Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

(2011) William W. Busse et al.   NEW ENGLAND JOURNAL OF MEDICINE